[go: up one dir, main page]

DK1372652T3 - Kombination af docetaxel og flavopiridol - Google Patents

Kombination af docetaxel og flavopiridol

Info

Publication number
DK1372652T3
DK1372652T3 DK02737950T DK02737950T DK1372652T3 DK 1372652 T3 DK1372652 T3 DK 1372652T3 DK 02737950 T DK02737950 T DK 02737950T DK 02737950 T DK02737950 T DK 02737950T DK 1372652 T3 DK1372652 T3 DK 1372652T3
Authority
DK
Denmark
Prior art keywords
flavopiridol
docetaxel
combination
Prior art date
Application number
DK02737950T
Other languages
Danish (da)
English (en)
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1372652T3 publication Critical patent/DK1372652T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02737950T 2001-03-23 2002-03-22 Kombination af docetaxel og flavopiridol DK1372652T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27794801P 2001-03-23 2001-03-23
US30269201P 2001-07-05 2001-07-05
US33491601P 2001-12-04 2001-12-04
PCT/EP2002/004083 WO2002076484A2 (en) 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase inhibitor

Publications (1)

Publication Number Publication Date
DK1372652T3 true DK1372652T3 (da) 2008-09-22

Family

ID=27402954

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02737950T DK1372652T3 (da) 2001-03-23 2002-03-22 Kombination af docetaxel og flavopiridol

Country Status (33)

Country Link
US (2) US20020182204A1 (xx)
EP (1) EP1372652B1 (xx)
JP (1) JP2004521140A (xx)
KR (1) KR100879712B1 (xx)
CN (1) CN1498107A (xx)
AR (1) AR034222A1 (xx)
AT (1) ATE395917T1 (xx)
AU (1) AU2002312815B2 (xx)
BR (1) BR0208221A (xx)
CA (1) CA2441441C (xx)
CY (1) CY1110449T1 (xx)
CZ (1) CZ301423B6 (xx)
DE (1) DE60226710D1 (xx)
DK (1) DK1372652T3 (xx)
EA (1) EA007815B1 (xx)
ES (1) ES2305253T3 (xx)
HR (1) HRPK20030766B3 (xx)
HU (1) HU229258B1 (xx)
IL (2) IL158058A0 (xx)
ME (1) MEP16408A (xx)
MX (1) MXPA03007743A (xx)
NO (1) NO332441B1 (xx)
NZ (1) NZ527655A (xx)
PE (1) PE20020907A1 (xx)
PL (1) PL206118B1 (xx)
PT (1) PT1372652E (xx)
RS (1) RS50681B (xx)
SI (1) SI1372652T1 (xx)
SK (1) SK287481B6 (xx)
TW (1) TWI355935B (xx)
UY (1) UY27220A1 (xx)
WO (1) WO2002076484A2 (xx)
ZA (1) ZA200307381B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE361746T1 (de) * 2002-03-06 2007-06-15 Medical Res And Education Trus Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin
WO2004035034A2 (en) * 2002-10-16 2004-04-29 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
AU2003276467A1 (en) * 2002-11-06 2004-06-07 Cyclacel Limited Combination comprising docetaxel and a cdk inhibitor
US8084027B2 (en) * 2006-02-10 2011-12-27 Nerviano Medical Sciences S.R.L. Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic
RU2013127655A (ru) * 2010-11-19 2014-12-27 Пирамал Энтерпрайзис Лимитед Фармацевтическая комбинация паклитаксела и ингибитора cdk
LT2694056T (lt) * 2011-04-01 2019-12-10 Astrazeneca Ab Terapinis gydymas
ES2762250T5 (es) 2011-11-30 2023-01-05 Astrazeneca Ab Tratamiento combinado del cáncer
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
EP0888458A4 (en) * 1996-02-20 2004-05-06 Sloan Kettering Institutefor C COMBINATION OF PKC INHIBITORS AND THERAPEUTIC AGENTS FOR TREATING CANCER

Also Published As

Publication number Publication date
MEP16408A (en) 2010-10-10
CZ20032551A3 (en) 2004-07-14
HRP20030766A2 (en) 2005-06-30
IL158058A (en) 2010-02-17
SI1372652T1 (sl) 2008-10-31
PL367702A1 (en) 2005-03-07
AU2002312815B2 (en) 2006-08-24
SK11692003A3 (sk) 2004-03-02
YU69503A (sh) 2006-08-17
UY27220A1 (es) 2002-09-30
US20020182204A1 (en) 2002-12-05
CY1110449T1 (el) 2015-04-29
NO332441B1 (no) 2012-09-17
HUP0303589A2 (hu) 2004-03-01
TWI355935B (en) 2012-01-11
AR034222A1 (es) 2004-02-04
KR100879712B1 (ko) 2009-01-22
EA200301053A1 (ru) 2004-02-26
WO2002076484A2 (en) 2002-10-03
CA2441441C (en) 2009-05-26
WO2002076484A3 (en) 2003-01-03
PL206118B1 (pl) 2010-07-30
NZ527655A (en) 2006-03-31
IL158058A0 (en) 2004-03-28
SK287481B6 (sk) 2010-11-08
CN1498107A (zh) 2004-05-19
CA2441441A1 (en) 2002-10-03
EP1372652A2 (en) 2004-01-02
NO20034124D0 (no) 2003-09-16
ATE395917T1 (de) 2008-06-15
HUP0303589A3 (en) 2007-05-02
BR0208221A (pt) 2004-03-02
HU229258B1 (en) 2013-10-28
PT1372652E (pt) 2008-07-24
HRPK20030766B3 (en) 2006-11-30
DE60226710D1 (de) 2008-07-03
US20060128640A1 (en) 2006-06-15
ZA200307381B (en) 2005-03-30
NO20034124L (no) 2003-09-16
EA007815B1 (ru) 2007-02-27
MXPA03007743A (es) 2004-11-12
ES2305253T3 (es) 2008-11-01
CZ301423B6 (cs) 2010-02-24
RS50681B (sr) 2010-06-30
JP2004521140A (ja) 2004-07-15
EP1372652B1 (en) 2008-05-21
PE20020907A1 (es) 2002-12-19
KR20030086318A (ko) 2003-11-07

Similar Documents

Publication Publication Date Title
EP1412378A4 (en) APTAMERES AND ANTIAPTAMERS
NO20041975D0 (no) Bicyklisk oksopyridin og oksopyrimidinderivater
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DK1404809T3 (da) Forbedrede hudsubstitutter og anvendelser deraf
DE50209252D1 (de) Distraktionsvorrichtung
NO20033456D0 (no) Modifiserte og stabiliserte GDF-propeptider og anvendelse derav
DE60232893D1 (de) Wirbelimplantat
IS7344A (is) Stýrð efnasmíði síprasídóns og samsetninga af því
NO20034212L (no) Kvartsglasskomponent og fremstilling derav
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DK1216046T3 (da) Hidtil ukendt kombination af loteprednol og antihistaminer
NO20021786D0 (no) Skumdempningsfremgangsmåter og sammensetninger
DE60220486D1 (de) Zurückschaltungseinrichtung und Zurückschaltungsverfahren
DK1562918T3 (da) Substituerede benzoxazinoner og anvendelser deraf
DE60229938D1 (de) ENTWICKLUNGSEINRICHTUNG UND BILDformungsgerät
DE60204749D1 (de) Abtast- und Halteschaltung
NO20054095D0 (no) Pyridyloksymetyl og benzioksazolazabicyklisk derivater
DK2305689T3 (da) Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelser
DK1359979T3 (da) Anticancer-kombination af substituerede pyrroler og paclitaxel
DK1372652T3 (da) Kombination af docetaxel og flavopiridol
IS7783A (is) Flóð og fjöru-ker
DK1441746T3 (da) Sammens tning og fremgangsmode
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter